Drug Shortage Report for OZEMPIC
Report ID | 202216 |
Drug Identification Number | 02471469 |
Brand name | OZEMPIC |
Common or Proper name | Ozempic |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SEMAGLUTIDE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 |
ATC code | A10BJ |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-08-21 |
Actual start date | |
Estimated end date | 2024-03-31 |
Actual end date | 2024-01-17 |
Shortage status | Resolved |
Updated date | 2024-04-05 |
Company comments | Due to the combination of overall global supply constraints coupled with increased demand, Novo Nordisk Canada Inc. is experiencing continued temporary delays on the shipments and delivery of Ozempic®. While we continue to manufacture and ship Ozempic®, patients may experience delays. We are working hard to address this issue and taking all relevant actions to ensure a continuous supply of medicine to Canadian patients. We will continue to monitor wholesale orders for extreme exceptions above normal demand, ensuring equal access for our patients |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2024-04-05 | English | Compare |
v21 | 2024-01-18 | English | Compare |
v20 | 2024-01-17 | French | Compare |
v19 | 2024-01-17 | English | Compare |
v18 | 2023-12-12 | English | Compare |
v17 | 2023-10-30 | French | Compare |
v16 | 2023-10-30 | English | Compare |
v15 | 2023-10-13 | French | Compare |
v14 | 2023-10-13 | English | Compare |
v13 | 2023-09-29 | French | Compare |
v12 | 2023-09-29 | English | Compare |
v11 | 2023-08-22 | English | Compare |
v10 | 2023-08-18 | French | Compare |
v9 | 2023-08-18 | English | Compare |
v8 | 2023-08-18 | French | Compare |
v7 | 2023-08-18 | English | Compare |
v6 | 2023-08-17 | French | Compare |
v5 | 2023-08-17 | English | Compare |
v4 | 2023-08-17 | French | Compare |
v3 | 2023-08-17 | English | Compare |